Development and validation of the CAIL prognostic score in non ‐small cell lung cancer patients with malignant pleural effusion
ConclusionsFor NSCLC patients with MPE, the validated CAIL prognostic score integrates clinical characteristics and therapeutic modalities to predict survival.
Source: The Clinical Respiratory Journal - Category: Respiratory Medicine Authors: Tianyuan Li,
Panwen Tian,
Qin Huang,
Hao Zeng,
Qi Wei,
Yalun Li Tags: ORIGINAL ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Respiratory Medicine | Study | Training | Universities & Medical Training